Reconstruction of the Nipple-Areola Complex in Chemotherapy Treated Skin: The Clinical Role of Medical Dermopigmentation
Paola Gateño
ABTSRACT
Medical dermopigmentation of the nipple-areola complex has become established as a minimally invasive reconstructive alternative in patients undergoing mastectomy for breast cancer, including those treated with chemotherapy and radiotherapy. Oncological therapies can cause persistent skin alterations, such as dermal thinning, fibrosis, tissue retraction, and changes in vascularization - factors that influence the choice and execution of reconstructive techniques. The present study describes a clinical series of ten cases of nipple-areola complex reconstruction using medical dermopigmentation, applied in different post-mastectomy scenarios and types of breast reconstruction. The procedure was performed following a standardized technical protocol, taking into account skin condition, prior oncological treatments, and the need to optimize pigment retention and procedural safety. Clinical results demonstrate adequate pigment integration, absence of major complications, and a high degree of patient-reported satisfaction. Medical dermopigmentation is presented as a safe and effective reconstructive option for skin treated with chemotherapy, providing immediate and reproducible results within the context of breast reconstruction.
